MicroRNA-509-5p functions as an anti-oncogene in breast cancer via targeting SOD2

Y-H Song1, J Wang, G Nie

  • 1Breast Center, Affiliated Hospital of Qingdao University, Qingdao, P.R. China. qdsongyh@163.com.

Abstract

Insights

MicroRNA-509-5p (miR-509-5p) acts as a tumor suppressor in breast cancer by inhibiting cell growth and metastasis. Targeting miR-509-5p and its downstream effector, SOD2, offers a potential therapeutic strategy for breast cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Breast cancer is a leading cause of cancer-related mortality in women globally.
  • Existing therapies for breast cancer often have limited efficacy, necessitating novel therapeutic targets.
  • Understanding the molecular mechanisms underlying breast cancer progression is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role of microRNA-509-5p (miR-509-5p) in regulating breast cancer cell growth and metastasis.
  • To identify potential therapeutic targets for breast cancer treatment based on miR-509-5p function.

Main Methods:

  • Quantitative Real-time PCR (qRT-PCR) to measure miR-509-5p expression.
  • Cell viability, proliferation, migration, invasion, apoptosis, and cell cycle assays (CCK8, colony formation, migration/invasion assays, flow cytometry).
  • Western blotting for protein analysis, bioinformatics, and luciferase assays to identify and validate miR-509-5p targets.

Main Results:

  • miR-509-5p was significantly downregulated in breast cancer tissues.
  • Overexpression of miR-509-5p suppressed breast cancer cell viability, proliferation, migration, and invasion.
  • miR-509-5p promoted apoptosis and induced G0/G1 cell cycle arrest.
  • Superoxide dismutase 2 (SOD2) was identified as a direct target of miR-509-5p.
  • Restoring SOD2 expression reversed the tumor-suppressive effects of miR-509-5p.

Conclusions:

  • miR-509-5p exhibits tumor-suppressive properties against breast cancer progression and metastasis by targeting SOD2.
  • miR-509-5p serves as a potential diagnostic and therapeutic target for breast cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.6K